Lonza's sales fell 5% to CHF1,193m in H1 2011, with the company reporting pressures of unfavourable exchange rates. However, the company reported that it had increased its project pipeline in both chemical and biological manufacturing. Additionally the company said its capacity utilisation was around 80% for both parts of its custom manufacturing business.
Reuters
Wednesday, 27 July 2011
Currency puts pressure on Lonza
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment